￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Dacomitinib is a targeted drug of several generations. Has dacomitinib been included in medical insurance?

2025-10-19 11:44:20

Check Details
FDA approves Mobocertinib to treat NSCLC with EGFR exon 20 insertion mutation

2025-10-19 11:44:20

Check Details
Brigatinib treats patients with ALK+ non-small cell lung cancer, and the progression-free survival benefit is more obvious!

2025-10-19 11:44:20

Check Details
Data on the effectiveness of the MET inhibitor capmatinib in the treatment of lung cancer_ Kanghule

2025-10-19 11:44:20

Check Details
Capmatinib has a significant effect in the treatment of MET mutated lung cancer

2025-10-19 11:44:20

Check Details
Dosage and administration method of anticancer drug crizotinib

2025-10-19 11:44:20

Check Details
Gefitinib is a new targeted drug for the treatment of advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
The emergence of crizotinib brings survival benefits to patients with non-small cell lung cancer

2025-10-19 11:44:20

Check Details
The effect of gefitinib treatment on patients with advanced lung cancer

2025-10-19 11:44:20

Check Details
Can lung cancer brain metastases be treated with gefitinib?

2025-10-19 11:44:20

Check Details
Safety and effectiveness of gefitinib targeted treatment of advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Tepotinib is a potent and highly selective oral MET inhibitor_ Kanghule

2025-10-19 11:44:20

Check Details
Category
相关知识